Lista de obras -

Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis.

artículo científico publicado en 2014

Acute-on-Chronic Liver Failure: The Role of Precipitating Illness

artículo científico publicado en 2016

Acute-on-chronic liver failure: an update.

artículo científico publicado en 2017

Adipocyte Fatty-Acid Binding Protein is Overexpressed in Cirrhosis and Correlates with Clinical Outcomes

artículo científico publicado en 2017

Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study

artículo científico publicado en 2012

Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis.

artículo científico publicado en 2015

Assessment of acute kidney injury at hospital admission in cirrhosis: estimating baseline serum creatinine is not the answer.

artículo científico publicado en 2015

Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome.

artículo científico publicado en 2018

Cell death markers in cirrhotic patients with acute decompensation.

artículo científico publicado en 2017

Challenges and Management of Liver Cirrhosis: Pathophysiology of Renal Dysfunction in Cirrhosis.

artículo científico

Characterization of Inflammatory Response in Acute-on-Chronic Liver Failure and Relationship with Prognosis.

artículo científico publicado en 2016

Chronic Kidney Disease in Cirrhosis: Emerging Complication With Negative Impact in the Liver Transplant Setting

scientific article published on 06 March 2020

Chronic kidney disease: a major concern in liver transplantation in the XXI century

artículo científico publicado en 2014

Combined liver-kidney transplantation in patients with cirrhosis and chronic kidney disease.

artículo científico publicado en 2010

Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline.

artículo científico publicado en 2018

Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival

artículo científico publicado en 2017

Editorial: evaluating cirrhosis progression-lessons from the heart

artículo científico publicado en 2019

Editorial: macrophage activation markers predict prognosis and decompensation in patients with cirrhosis-linking gut permeability, inflammation and cirrhosis progression.

artículo científico publicado en 2018

Effects of alfapump™ system on kidney and circulatory function in patients with cirrhosis and refractory ascites.

artículo científico publicado en 2017

Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema.

artículo científico publicado en 2012

Fe de errores de «Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica» [Gastroenterol Hepatol. 2018;41(5):328-349]

scientific article published on 01 August 2018

Hepatorenal syndrome in the era of acute kidney injury

scientific article published on 19 June 2018

Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension.

artículo científico publicado en 2010

Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study

artículo científico publicado en 2014

LEFT ventricular function assessed by echocardiography in cirrhosis: Relationship to systemic hemodynamics and renal dysfunction

scientific article published on 16 September 2012

Limited Efficacy of Tolvaptan in Patients with Cirrhosis and Severe Hyponatremia: Real-Life Experience.

artículo científico publicado en 2016

Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF).

artículo científico publicado en 2015

Management of uninfected and infected ascites in cirrhosis.

artículo científico

Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis

artículo científico publicado en 2016

Plasma copeptin as biomarker of disease progression and prognosis in cirrhosis.

artículo científico publicado en 2016

Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome.

artículo científico publicado en 2010

Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study

artículo científico publicado en 2012

Pro: Acute-on-chronic liver failure.

artículo científico publicado en 2017

Prognostic Importance of the Cause of Renal Failure in Patients With Cirrhosis

artículo científico publicado en 2010

Relationship between noninvasive scores of nonalcoholic fatty liver disease and nuclear magnetic resonance lipoprotein abnormalities: A focus on atherogenic dyslipidemia.

artículo científico publicado en 2017

Renal and circulatory dysfunction in cirrhosis: current management and future perspectives.

scientific article published on 13 August 2010

Renal failure and hyponatremia in patients with cirrhosis and skin and soft tissue infection. A retrospective study.

artículo científico publicado en 2012

Reply to: "A cut-off serum creatinine value of 1.5 mg/dl for AKI--to be or not to be"

Reply to: "Are we still searching for the fifth element of MELD?"

artículo científico publicado en 2016

Reply to: "To close the stable door before the horse has bolted".

artículo científico publicado en 2013

Response to nosocomial spontaneous bacterial peritonitis: discussing a specific infection treatment algorithm

artículo científico publicado en 2016

Severe acute kidney injury associated with non-steroidal anti-inflammatory drugs in cirrhosis: A case-control study

artículo científico publicado en 2015

Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis

artículo científico publicado en 2014

Treatment of type 2 hepatorenal syndrome in patients awaiting transplantation: Effects on kidney function and transplantation outcomes

artículo científico publicado en 2015

Type-1 hepatorenal syndrome associated with infections in cirrhosis: natural history, outcome of kidney function, and survival

artículo científico publicado en 2014

Update on acute-on-chronic liver failure.

artículo científico publicado en 2017

Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis

scientific article published on 17 April 2012

Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections

artículo científico publicado en 2014

Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis.

artículo científico publicado en 2016

Validation of a Staging System for Acute Kidney Injury in Patients With Cirrhosis and Association With Acute-on-Chronic Liver Failure

artículo científico publicado en 2016

[Evaluation and treatment of the critically ill cirrhotic patient].

artículo científico publicado en 2016

Lista de obras de

Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis.

Acute-on-Chronic Liver Failure: The Role of Precipitating Illness

Acute-on-chronic liver failure: an update.

Adipocyte Fatty-Acid Binding Protein is Overexpressed in Cirrhosis and Correlates with Clinical Outcomes

Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study

Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis.

Assessment of acute kidney injury at hospital admission in cirrhosis: estimating baseline serum creatinine is not the answer.

Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome.

Cell death markers in cirrhotic patients with acute decompensation.

Challenges and Management of Liver Cirrhosis: Pathophysiology of Renal Dysfunction in Cirrhosis.

Characterization of Inflammatory Response in Acute-on-Chronic Liver Failure and Relationship with Prognosis.

Chronic Kidney Disease in Cirrhosis: Emerging Complication With Negative Impact in the Liver Transplant Setting

Chronic kidney disease: a major concern in liver transplantation in the XXI century

Combined liver-kidney transplantation in patients with cirrhosis and chronic kidney disease.

Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline.

Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival

Editorial: evaluating cirrhosis progression-lessons from the heart

Editorial: macrophage activation markers predict prognosis and decompensation in patients with cirrhosis-linking gut permeability, inflammation and cirrhosis progression.

Effects of alfapump™ system on kidney and circulatory function in patients with cirrhosis and refractory ascites.

Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema.

Fe de errores de «Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica» [Gastroenterol Hepatol. 2018;41(5):328-349]

Hepatorenal syndrome in the era of acute kidney injury

Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension.

Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study

LEFT ventricular function assessed by echocardiography in cirrhosis: Relationship to systemic hemodynamics and renal dysfunction

Limited Efficacy of Tolvaptan in Patients with Cirrhosis and Severe Hyponatremia: Real-Life Experience.

Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF).

Management of uninfected and infected ascites in cirrhosis.

Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis

Plasma copeptin as biomarker of disease progression and prognosis in cirrhosis.

Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome.

Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study

Pro: Acute-on-chronic liver failure.

Prognostic Importance of the Cause of Renal Failure in Patients With Cirrhosis

Relationship between noninvasive scores of nonalcoholic fatty liver disease and nuclear magnetic resonance lipoprotein abnormalities: A focus on atherogenic dyslipidemia.

Renal and circulatory dysfunction in cirrhosis: current management and future perspectives.

Renal failure and hyponatremia in patients with cirrhosis and skin and soft tissue infection. A retrospective study.

Reply to: "A cut-off serum creatinine value of 1.5 mg/dl for AKI--to be or not to be"

Reply to: "Are we still searching for the fifth element of MELD?"

Reply to: "To close the stable door before the horse has bolted".

Response to nosocomial spontaneous bacterial peritonitis: discussing a specific infection treatment algorithm

Severe acute kidney injury associated with non-steroidal anti-inflammatory drugs in cirrhosis: A case-control study

Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis

Treatment of type 2 hepatorenal syndrome in patients awaiting transplantation: Effects on kidney function and transplantation outcomes

Type-1 hepatorenal syndrome associated with infections in cirrhosis: natural history, outcome of kidney function, and survival

Update on acute-on-chronic liver failure.

Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis

Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections

Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis.

Validation of a Staging System for Acute Kidney Injury in Patients With Cirrhosis and Association With Acute-on-Chronic Liver Failure

[Evaluation and treatment of the critically ill cirrhotic patient].